DK1015494T3 - Fremgangsmåde til fremstilling af katalytiske antistoffer - Google Patents
Fremgangsmåde til fremstilling af katalytiske antistofferInfo
- Publication number
- DK1015494T3 DK1015494T3 DK98943578T DK98943578T DK1015494T3 DK 1015494 T3 DK1015494 T3 DK 1015494T3 DK 98943578 T DK98943578 T DK 98943578T DK 98943578 T DK98943578 T DK 98943578T DK 1015494 T3 DK1015494 T3 DK 1015494T3
- Authority
- DK
- Denmark
- Prior art keywords
- growth factor
- present
- factor precursor
- catalytic antibodies
- nucleic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0002—Antibodies with enzymatic activity, e.g. abzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/624—Disulfide-stabilized antibody (dsFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO9306A AUPO930697A0 (en) | 1997-09-19 | 1997-09-19 | Catalytic antibodies and a method of producing same |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1015494T3 true DK1015494T3 (da) | 2006-05-01 |
Family
ID=3803589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98943578T DK1015494T3 (da) | 1997-09-19 | 1998-09-18 | Fremgangsmåde til fremstilling af katalytiske antistoffer |
Country Status (12)
Country | Link |
---|---|
US (3) | US6590080B1 (de) |
EP (1) | EP1015494B1 (de) |
AT (1) | ATE312845T1 (de) |
AU (1) | AUPO930697A0 (de) |
CA (1) | CA2304365A1 (de) |
DE (1) | DE69832804T2 (de) |
DK (1) | DK1015494T3 (de) |
ES (1) | ES2253824T3 (de) |
GB (1) | GB2345694B (de) |
HK (1) | HK1029350A1 (de) |
NZ (3) | NZ503454A (de) |
WO (1) | WO1999015563A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU731580B2 (en) * | 1996-03-26 | 2001-04-05 | Frank Koentgen | Precursors of catalytic antibodies |
US20060128615A1 (en) * | 2002-09-18 | 2006-06-15 | Pierrette Gaudreau | Ghrh analogues |
WO2005000898A2 (en) | 2003-06-27 | 2005-01-06 | Biogen Idec Ma Inc. | Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
EP1697415A1 (de) | 2003-11-12 | 2006-09-06 | Biogen Idec MA Inc. | Polypeptidvarianten, die an den neonatal-fc-receptor (fcrn) binden, dimere fc-bindende proteine und damit in zusammenhang stehende verfahren |
WO2005113584A1 (en) * | 2004-04-29 | 2005-12-01 | Board Of Regents, University Of Texas System | Methods and compositions comprising protein l immunoglobulin binding domains for cell-specific targeting |
CN101534848B (zh) | 2006-09-19 | 2013-07-17 | 亚洲大学校产学协力团 | 抗动物病毒的抗病毒剂 |
US10585098B2 (en) | 2009-11-23 | 2020-03-10 | The Johns Hopkins University | Optimizing diagnostics for galactofuranose containing antigens |
US10288611B2 (en) | 2009-11-23 | 2019-05-14 | The Johns Hopkins University | Lateral flow device for diagnosing microbial infections |
WO2013012733A1 (en) | 2011-07-15 | 2013-01-24 | Biogen Idec Ma Inc. | Heterodimeric fc regions, binding molecules comprising same, and methods relating thereto |
EP2565667A1 (de) | 2011-08-31 | 2013-03-06 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Ankunftsrichtungsschätzung mittels mit einem Wasserzeichen versehenen Audiosignalen und Mikrofonanordnungen |
NZ718283A (en) | 2013-09-25 | 2022-05-27 | Cytomx Therapeutics Inc | Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof |
WO2015095195A1 (en) | 2013-12-16 | 2015-06-25 | The Johns Hopkins University | Interferon-gamma release assays for diagnosis of invasive fungal infections |
AU2015210862B2 (en) | 2014-01-31 | 2020-04-23 | Cytomx Therapeutics, Inc | Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof |
MA41374A (fr) | 2015-01-20 | 2017-11-28 | Cytomx Therapeutics Inc | Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985002414A1 (en) * | 1983-11-29 | 1985-06-06 | Igen, Inc. | Method of catalyzing chemical reactions |
US5126258A (en) * | 1984-09-07 | 1992-06-30 | Scripps Clinic And Research Foundation | Molecules with antibody combining sites that exhibit catalytic properties |
US4900674A (en) * | 1987-05-28 | 1990-02-13 | Scripps Clinic And Research Foundation | Antibody combining sites that exhibit amide or ester synthase activity |
US5190865A (en) * | 1988-11-18 | 1993-03-02 | The Regents Of The University Of California | Antibody-enhanced stereospecific hydrolyses |
US5215889A (en) * | 1988-11-18 | 1993-06-01 | The Regents Of The University Of California | Catalytic and reactive polypeptides and methods for their preparation and use |
US5219732A (en) * | 1989-09-05 | 1993-06-15 | The Regents Of The University Of California | Antibody-mediated cofactor-driven reactions |
US5187086A (en) * | 1990-01-26 | 1993-02-16 | Scripps Clinic And Research Foundation | Molecules with antibody combining sites that catalyze hydrolysis reactions through use of a charged hapten |
SE9002212D0 (sv) * | 1990-06-21 | 1990-06-21 | Hightech Receptor Ab | Igg binding protein |
KR100334697B1 (ko) * | 1991-08-05 | 2002-04-27 | 리차아드제이마세이 | 표적화된 촉매 단백질에 의해 활성화되는 선구 약제 |
IL104829A (en) * | 1992-02-24 | 1999-04-11 | Igen Inc | Selection is based on a response to the expression and concentration of catalytic units |
US5439812A (en) * | 1992-04-08 | 1995-08-08 | The Pennsylvania Research Corporation | Antibodies catalyzing deamidation of proteins |
SE9201331D0 (sv) * | 1992-04-28 | 1992-04-28 | Hightech Receptor C O Active | Protein l och hybridproteiner daerav |
GB9209804D0 (en) * | 1992-05-07 | 1992-06-24 | Health Lab Service Board | Novel immunoglobulin binding proteins process for their production and recombinant dna molecules coding therefor |
GB2326643B (en) * | 1996-03-26 | 2000-09-27 | Amrad Operations Pty Ltd | Precursors of catalytic antibodies |
AU731580B2 (en) * | 1996-03-26 | 2001-04-05 | Frank Koentgen | Precursors of catalytic antibodies |
US7253178B2 (en) * | 2001-03-28 | 2007-08-07 | Eisai Co., Ltd. | Carboxylic acids |
TWI311133B (en) * | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
WO2002098840A1 (fr) * | 2001-06-04 | 2002-12-12 | Eisai Co., Ltd. | Derive de l'acide carboxylique et medicament comprenant un sel ou un ester dudit derive |
EP1452521A4 (de) * | 2001-08-17 | 2007-03-14 | Eisai R&D Man Co Ltd | Cyclische verbindung und ppar-agonist |
-
1997
- 1997-09-19 AU AUPO9306A patent/AUPO930697A0/en not_active Abandoned
-
1998
- 1998-09-18 GB GB0009758A patent/GB2345694B/en not_active Expired - Fee Related
- 1998-09-18 DE DE69832804T patent/DE69832804T2/de not_active Expired - Lifetime
- 1998-09-18 NZ NZ503454A patent/NZ503454A/en active Application Revival
- 1998-09-18 EP EP98943578A patent/EP1015494B1/de not_active Expired - Lifetime
- 1998-09-18 WO PCT/AU1998/000783 patent/WO1999015563A1/en active IP Right Grant
- 1998-09-18 NZ NZ524429A patent/NZ524429A/en unknown
- 1998-09-18 US US09/509,031 patent/US6590080B1/en not_active Expired - Fee Related
- 1998-09-18 CA CA002304365A patent/CA2304365A1/en not_active Abandoned
- 1998-09-18 ES ES98943578T patent/ES2253824T3/es not_active Expired - Lifetime
- 1998-09-18 AT AT98943578T patent/ATE312845T1/de not_active IP Right Cessation
- 1998-09-18 NZ NZ515603A patent/NZ515603A/xx unknown
- 1998-09-18 DK DK98943578T patent/DK1015494T3/da active
-
2000
- 2000-12-29 HK HK00108566A patent/HK1029350A1/xx not_active IP Right Cessation
-
2003
- 2003-01-16 US US10/345,618 patent/US20030148484A1/en not_active Abandoned
-
2007
- 2007-10-31 US US11/981,116 patent/US20090269355A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999015563A9 (en) | 1999-06-03 |
EP1015494A1 (de) | 2000-07-05 |
GB0009758D0 (en) | 2000-06-07 |
HK1029350A1 (en) | 2001-03-30 |
WO1999015563A1 (en) | 1999-04-01 |
ES2253824T3 (es) | 2006-06-01 |
DE69832804D1 (de) | 2006-01-19 |
AUPO930697A0 (en) | 1997-10-09 |
US20030148484A1 (en) | 2003-08-07 |
NZ515603A (en) | 2003-04-29 |
EP1015494B1 (de) | 2005-12-14 |
DE69832804T2 (de) | 2006-08-10 |
ATE312845T1 (de) | 2005-12-15 |
US20090269355A1 (en) | 2009-10-29 |
CA2304365A1 (en) | 1999-04-01 |
EP1015494A4 (de) | 2001-12-12 |
NZ503454A (en) | 2004-01-30 |
US6590080B1 (en) | 2003-07-08 |
NZ524429A (en) | 2004-06-25 |
GB2345694A (en) | 2000-07-19 |
GB2345694B (en) | 2002-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1015494T3 (da) | Fremgangsmåde til fremstilling af katalytiske antistoffer | |
BR0010806A (pt) | Métodos e materiais para a sìntese de produtos orgânicos | |
MY162525A (en) | Process for concentration of antibodies and therapeutic products thereof | |
HU9303023D0 (en) | Peptide nucleicadis and method for producing them | |
FI942237A0 (fi) | Lysosomaalientsyymin pilkkoamia kasvaintenvastaisia lääkeainekonjugaatteja | |
DK0853487T3 (da) | Neutraliserende monoklonale antistoffer mod respiratorisk syncytial virus | |
DK0986644T3 (da) | Fremstilling af erythropoietin ved endogen genaktivering med virale promotorer | |
TR200002731T2 (tr) | Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar | |
EP1808180A3 (de) | Modifiziertes GP 100 und Verwendung dafür | |
DE59912185D1 (de) | Verwendung von hsp70 protein | |
KR970705408A (ko) | 헤모필루스 부착 및 침투 단백질(haemophilus adherence and penetration proteins) | |
WO2004102198A3 (en) | Selection of b cells with specificity of interest: method of preparation and use | |
GB2326643B (en) | Precursors of catalytic antibodies | |
BR0212504A (pt) | Materiais e métodos para vacina de células t autólogas | |
ATE458037T1 (de) | Grosstechnisch geeigneter mikroorganismus | |
CO5650177A2 (es) | Constructos geneticos y composiciones que comprenden rre y cte y usos de estos | |
ATE505550T1 (de) | Fermentationsverfahren | |
WO2001030989A3 (en) | Method for creating divergent populations of nucleic acid molecules and proteins | |
DK1001929T3 (da) | Fremgangsmåde til fremstilling af 3-cyano-2,4-dihalogen-5-flour-benzoesyrer | |
ES2177762T3 (es) | Procedimiento para producir cis-2-hidrixi-l-prolina. | |
ITMI910861A1 (it) | Procedimento migliorato per la preparazione di polipeptidi maturi | |
Parikh | Purification and characterization of hemorrhagic factor from Crotalus atrox (Western diamondback rattlesnake) venom by high performance liquid chromatography (HPLC) and production of monoclonal antibody. | |
HUT53593A (en) | Process for producing optically active n-(terc butoxy-carbonyl)-o-benzyl-serine and n-(terc butoxy-carbonyl)-o-benzyl-treonine | |
MX9802766A (es) | Vacuna contra la influenza. |